17077 studies found for:
"Nervous System Diseases"
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Completed |
Genotype/Phenotype Correlation of Movement Disorders and Other Neurological Diseases
|
||||
| 2 | Active, not recruiting |
(1)H-Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in Patients Who Receive Neurotoxic Therapy
|
||||
| 3 | Unknown † |
Autologous Mesenchymal Stem Cells From Adipose Tissue in Patients With Secondary Progressive Multiple Sclerosis
|
||||
| 4 | Recruiting |
Effect of Undenatured Cysteine-Rich Whey Protein Isolate (HMS 90®) in Patients With Parkinson's Disease
|
||||
| 5 | Completed |
Vascular Risk Factors in INPH-patients
|
||||
| 6 | Enrolling by invitation |
The GORE FREEDOM Study
|
||||
| 7 | Recruiting |
A Longitudinal Study of Amyotrophic Lateral Sclerosis (ALS) Biomarkers
|
||||
| 8 | Recruiting |
The Long-Term Safety and Efficacy Follow-Up Study of Subjects Who Completed the Phase I Clinical Trial of Neurostem®-AD
|
||||
| 9 | Recruiting |
Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases in Neurological Disorders in DRC
|
||||
| 10 | Recruiting |
Study of Inherited Neurological Disorders
|
||||
| 11 | Completed |
Central Nervous System Disease in HIV-infected Children on HAART
|
||||
| 12 | Active, not recruiting |
Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis
|
||||
| 13 | Completed |
Magnetic Resonance Imaging for the Study of Patients With Neurological Disorders
|
||||
| 14 | Terminated |
In Vitro NMR Spectroscopy in Neurological Diseases
|
||||
| 15 | Recruiting |
Training for Diagnosing Neurological Disorders
|
||||
| 16 | Completed |
A Follow-up Study to Assess Safety and Tolerability of Galantamine Treatment in Individuals With Mild Cognitive Impairment
|
||||
| 17 | Completed |
Sleep Disorders of Patients With Diseases of the Nervous System
|
||||
| 18 | Withdrawn |
Comparison Between Respiratory Therapy With Cough Assist Technique and Usual Respiratory Therapy in Intensive Care Patients Suffering of Neurologic Disorder
|
||||
| 19 | Recruiting |
Natural History Study of Patients With Neurofibromatosis Type 2
|
||||
| 20 | Terminated |
Augmenting Effects of L-DOPS With Carbidopa and Entacapone
|
† Indicates status has not been verified in more than two years
